Pectus 90ml Cough Syrup is primarily indicated in conditions like Acute urticaria, Advanced ovarian cancer, Allergic conjunctivitis, Angiooedema, Atopic dermatitis, Chronic urticaria, Emergency treatment of anaphylactic reaction, Seasonal allergic rhinitis, Transcervical operative procedures in first trimester, and can also be given in adjunctive therapy as an alternative drug of choice in Common cold.
Pectus 90ml Cough Syrup is contraindicated in conditions like Hypersensitivity.
The severe or irreversible adverse effects of Pectus 90ml Cough Syrup, which give rise to further complications include Sinus tachycardia, Jaundice, Jaundice, Seizures, Hypertension, CNS stimulation.Pectus 90ml Cough Syrup produces potentially life-threatening effects which include Bone marrow suppression. which are responsible for the discontinuation of Pectus 90ml Cough Syrup therapy. The signs and symptoms that are produced after the acute overdosage of Pectus 90ml Cough Syrup include Hypotension, Convulsions, Coma, Urinary retention, Unconsciousness, Fever, Dryness of mucous, Flushing membrane, Pupillary dilatation. The symptomatic adverse reactions produced by Pectus 90ml Cough Syrup are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Fatigue, Nausea, Vomiting, Restlessness, Palpitation, Constipation, Abdominal pain, Dry mouth, Blurred vision, Sedation, Polyuria, Facial dyskinesias, Blood dyscrasias, Xerostomia, Dry mouth.
Pectus 90ml Cough Syrup should be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not administer subcutaneously because irritation or lesion may occur.
There are no reviews yet.